Quigley v. Rider

593 S.E.2d 476, 357 S.C. 477, 2003 S.C. App. LEXIS 211
CourtCourt of Appeals of South Carolina
DecidedDecember 22, 2003
Docket3720
StatusPublished
Cited by2 cases

This text of 593 S.E.2d 476 (Quigley v. Rider) is published on Counsel Stack Legal Research, covering Court of Appeals of South Carolina primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Quigley v. Rider, 593 S.E.2d 476, 357 S.C. 477, 2003 S.C. App. LEXIS 211 (S.C. Ct. App. 2003).

Opinion

HOWARD, J.:

Keith P. Quigley, individually, and Donna Quigley, individually and on behalf of her minor child, Kealy Quigley (“Kealy”), brought this medical malpractice suit against John A. Rider, M.D. and Medical Park Pediatricians, P.A. (collectively “Rider”), alleging Rider committed malpractice by negligently administering a second and third diphtheria-pertussis-tetanus (“DPT”) shot to Kealy after she displayed an adverse reaction to the first shot. 1 The circuit court dismissed the suit, holding the court did not have subject matter jurisdiction because Kealy’s injuries were vaccine-related and were thus barred by the National Childhood Vaccine Injury Compensation Act, 42 U.S.C.A. § 300aa-1 to 300aa-34 (1988 as amended) (“the Act”). Donna Quigley appeals on behalf of Kealy (“Quigley”), *480 arguing Kealy’s injuries were not vaccine-related and Rider is equitably estopped from asserting the Act as a bar to the litigation. We affirm.

FACTUAL/PROCEDURAL BACKGROUND

Rider gave Kealy her first DPT shot in December 1988. Shortly thereafter, Kealy had adverse reactions to the shot. Quigley alleges that Rider knew of these adverse reactions but administered a second and third DPT shot to Kealy, both of which manifested corresponding adverse reactions. Subsequently, Kealy was diagnosed with severe mental and physical retardation, which Quigley attributes to the DPT shots.

Quigley filed this action, alleging Rider was negligent by administering the second and third DPT shots. Additionally, the complaint alleged Rider negligently failed to: 1) notify the Secretary of the Department of Health and Human Services (“the Secretary”) regarding Kealy’s reactions to the shots pursuant to 42 U.S.C.A. §§ 300aa-25(a) & (b); 2 and 2) inform Quigley of the dangers of the vaccine pursuant to 42 U.C.S.A. §§ 300aa-26(c) & (d). 3

Rider moved for dismissal, arguing the circuit court lacked subject matter jurisdiction over the claim. The court granted the motion, ruling the Act required Quigley to file a petition with the Federal Claims Court prior to seeking state court remedies. Quigley appeals.

LAW/ANALYSIS

I. General Overview of the Act

Congress created the Act in 1986 for the purpose of establishing an efficient scheme of recovery for injuries and *481 deaths traceable to vaccines, while providing protection for manufacturers and administrators of the vaccines. See H.R.Rep. No. 99-908, at 4 (1986), reprinted in, 1986 U.S.C.C.A.N. 6344, 6345 (“While most of the Nation’s children enjoy greater benefit from immunization programs, a small but significant number have been gravely injured. These children are often without a source of payment or compensation for their medical and rehabilitative needs, and they and their families have resorted in greater numbers to the tort system for some form of financial relief.”); Shalala v. Whitecotton, 514 U.S. 268, 269-70, 115 S.Ct. 1477, 131 L.Ed.2d 374 (1995) (citing H.R.Rep. No. 99-908, at 3-7 (1986)) (“For injuries and deaths traceable to vaccinations, the Act establishes a scheme of recovery designed to work faster and with greater ease than the civil tort system.”); Schafer v. American Cyanamid Co., 20 F.3d 1, 4 (1st Cir.1994) (“The Act seeks to achieve its cost-reducing purpose, not by denying compensation to victims ... but by reducing the litigation and insurance costs related to lengthy, complex tort procedures and random large tort awards. The Act therefore imposes substantive and procedural limitations upon tort actions.”); see also H.R.Rep. No. 99-908, at 6-7 (1986), reprinted in, 1986 U.S.C.C.A.N. 6344, 6348-49 (stating one of the primary purposes of the Act is to protect the vaccine market against the instability and uncertainty of tort litigation).

To meet the clearly stated goals of Congress, the Act provides a remedial scheme whereby a person who sustains vaccine-related injuries after the effective date of the Act must apply to the Federal Claims Court for compensation pursuant to the Act prior to seeking traditional tort remedies through state and federal courts. §§ 300aa-11(a)(2)(A)(i) and (ii); see Shalala, 514 U.S. at 270, 115 S.Ct. 1477 (citing § 300aa-11) (“A claimant alleging that more than $1,000 in damages resulted from a vaccination after the Act’s effective date in 1988 must exhaust the Act’s procedures and refuse to accept the resulting judgment before filing any de novo civil action in state or federal court.”) (emphasis as in original). However, once an injured person has appropriately applied to the Federal Claims Court under the Act and received a judgment, the person may choose to accept the judgment or pursue tradi *482 tional tort remedies in state and federal court. See § 300aa-21(a).

II. Vaccine-Related Injury

Quigley argues the circuit court erred by dismissing Kealy’s claims because Kealy’s injuries are not “vaccine-related injuries” within the scope of the Act. Quigley contends although Kealy’s injuries from the first DPT shot were “vaccine-related injuries,” Kealy’s injuries from the second and third DPT shots were not because Rider’s administrations of the second and third DPT shots were intervening and superseding factors, breaking the causal chain between the DPT shots and Kealy’s injuries. We disagree.

When the terms of a statute are clear and unambiguous, our inquiry ends, and we are required to enforce the terms of the statute as Congress drafted it. See United States v. Ron Pair Enters., Inc., 489 U.S. 235, 241-42, 109 S.Ct. 1026, 103 L.Ed.2d 290 (1989).

Section 300aa-111(a)(2)(A) states the Act only applies to a vaccine-related injury. The Act defines “vaccine-related injury” as “an illness, injury, condition, or death associated with one or more of the vaccines set forth in the Vaccine Injury Table ...” § 300aa-33(5) (emphasis added).

DPT is a vaccine listed within the Vaccine Injury Table. § 300aa-14. Furthermore, even under Quigley’s arguments, Kealy’s injuries are “associated ivith ” the DPT shots. 4 Thus, under any view of the negligence alleged, Kealy’s injuries are “vaccine-related injuries” within the scope of the Act. See Amendola v. Secretary, Dep’t of Health and Human Servs., 989 F.2d 1180, 1186-87 (Fed.Cir.1993) (holding injuries arising from allegations of medical malpractice stemming from multiple administrations of a vaccine within the Act are vaccine-related injuries subject to the Act).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Sullivan, L. v. Holy Redeemer Hospital
2021 Pa. Super. 191 (Superior Court of Pennsylvania, 2021)
Weston v. KIM'S DOLLAR STORE
684 S.E.2d 769 (Court of Appeals of South Carolina, 2009)

Cite This Page — Counsel Stack

Bluebook (online)
593 S.E.2d 476, 357 S.C. 477, 2003 S.C. App. LEXIS 211, Counsel Stack Legal Research, https://law.counselstack.com/opinion/quigley-v-rider-scctapp-2003.